Editas Medicine, Inc.

NASDAQ:EDIT

1.21 (USD) • At close December 24, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019201820172016201520142013
Revenue 78.12319.71225.54490.73220.53131.93713.7286.0531.62900
Cost of Revenue 177.6516.3375.053157.99696.89890.65483.15956.97918.8465.0731.59
Gross Profit -99.52813.37520.491-67.264-76.367-58.717-69.431-50.926-17.217-5.073-1.59
Gross Profit Ratio -1.2740.6790.802-0.741-3.72-1.839-5.058-8.413-10.56900
Reseach & Development Expenses 177.651174.958142.507157.99696.89890.65483.15956.97918.8465.0731.59
General & Administrative Expenses 69.65370.70476.18367.57664.55555.0150.50246.26218.0957.653.63
Selling & Marketing Expenses 00000000000
SG&A 69.65370.70476.18367.57664.55555.0150.50246.26218.0957.653.63
Other Expenses 01.293-1.69816.259-0.1370.3280.587-0.057-37.445-0.9280
Operating Expenses 247.304245.662218.69225.572161.453145.664133.661103.24136.94112.7233.684
Operating Income -169.181-225.95-193.146-134.84-140.922-113.727-119.933-97.188-35.312-12.723-5.22
Operating Income Ratio -2.166-11.463-7.561-1.486-6.864-3.561-8.736-16.056-21.67700
Total Other Income Expenses Net 15.9625.5180.64418.8647.1763.773-0.3910.005-37.588-0.962-0.054
Income Before Tax -153.219-220.432-192.502-115.976-133.746-109.954-120.324-97.183-72.9-13.685-5.274
Income Before Tax Ratio -1.961-11.183-7.536-1.278-6.514-3.443-8.765-16.055-44.75100
Income Tax Expense 0-16.08-7.395-6.564-10.28-3.117-1.118-1.321-37.773-0.8940.075
Net Income -153.219-204.352-185.107-109.412-123.466-109.954-120.324-97.183-72.9-13.685-5.349
Net Income Ratio -1.961-10.367-7.247-1.206-6.014-3.443-8.765-16.055-44.75100
EPS -2.02-2.98-2.74-1.87-2.47-2.33-2.98-3.02-2.04-0.89-17.8
EPS Diluted -2.02-2.98-2.74-1.87-2.47-2.33-2.98-3.02-2.04-0.89-17.8
EBITDA -163.117-219.613-188.093-130.881-138.092-110.473-116.663-96.068-72.286-13.494-5.217
EBITDA Ratio -2.088-11.463-7.561-1.486-6.871-3.551-8.694-16.066-44.66400